|
|
Eckenheimer Landstrasse 100 Frankfurt/Main, 60318 Germany phone:+49-(0)69 - 15 03 - 0 fax: +49-(0)69 - 15 03 - 200
|
|
| Symbol |
Private |
| Exchange |
|
| Founded |
0 |
| Employees |
|
|
|
| www.merz.de
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Drugs for neurological and psychiatric diseases. |
 |
| Management |
| Edward R. Roberts, Chairman; Michael Freiherr von Truchseß, assistant Chairman; Prof. Dr. Dr. h.c. Rolf Krebs; Prof. Dr. Harald Wiedmann; Prof. Dr. Dr. h.c. Bernhard Scheuble, CEO; Hartmut Erlinghagen, CAO; Armin von Buttlar, CFO; Dr. Martin Zügel, CEO Merz Pharmaceuticals |
| |
|
|
| |
|
| Keywords |
| neurological, psychiatric diseases, Alzheimer's, Parkinson's |
|
|
|
| Description |
|
Merz Pharma has three subsidiaries: Merz Pharmaceuticals, Merz Consumer Care and Merz Dental. Merz Pharmaceuticals concentrates its research and development activities on drugs for neurological and psychiatric diseases such as Alzheimer's dementia, Parkinson's disease, and neuromuscular disturbances such as dystonia and spasticity. |
 |
 |
|
|
|
|
|
|